Αποτελέσματα Αναζήτησης
During the 2009 H1N1 influenza pandemic nearly every decision associated with new vaccine development and dissemination occurred from the Spring of 2009, when the novel virus first emerged, to the Fall of 2009, when the new vaccines started reaching ...
14 Ιουλ 2010 · The objective was to determine the seroprevalence of antibodies against the pandemic 2009 H1N1 influenza strain by decade of birth among Pittsburgh-area residents. Methods and Findings. Anonymous blood samples were obtained from clinical laboratories and categorized by decade of birth from 1920–2009.
Between September 2009 and June 2010, >350 million doses of vaccine were administered, targeting various populations. As of 6 June 2010, more than 214 countries had reported laboratory-confirmed cases of pandemic A (H1N1) 2009 influenza, including at least 18 156 deaths.
15 Μαΐ 2016 · Overall, the effectiveness of vaccine against A (H1N1)pdm09-related MAARI was 54% (95% confidence interval [CI], 46%-61%). Among fully vaccinated children aged 2-17 years, the effectiveness of LAIV4 was 17% (95% CI, -39% to 51%) and the effectiveness of IIV was 60% (95% CI, 36%-74%).
14 Ιουλ 2010 · The objective was to determine the seroprevalence of antibodies against the pandemic 2009 H1N1 influenza strain by decade of birth among Pittsburgh-area residents. Methods and Findings Anonymous blood samples were obtained from clinical laboratories and categorized by decade of birth from 1920–2009.
In this analysis, the authors interviewed national, state, and local leaders to gain a better understanding of the accomplishments and challenges of H1N1 vaccination programs during the 2009-10 influenza season.
4 vaccines against 2009 H1N1 influenza approved by FDA. Healthy adults and older children found to need 1 dose of vaccine to generate strong immune response; children under 9 need two doses. Influenza activity peaks the second week of the month. October: 3 million doses of nasal spray are the first vaccine ready for distribution
